Trastuzumab in the Second-Line Treatment of HER2-Positive Metastatic Gastric Cancer. Experience of the Moscow Oncology Service. Вопр. онкол. [Internet]. 2026 May 8 [cited 2026 Oct. 14];72(2):OF-2514. Available from: https://voprosyonkologii.ru/index.php/journal/article/view/2-26-Trastuzumab